AVXL SG&A Expense Growth
Anavex Life Sciences Corp · SG&A Expense Growth
AVXL SG&A Expense Growth
Latest reported25.16%period ending
AVXL FY SG&A Growth (YoY) (0.00% → 25.16%)
Latest values, visible window
High-resolution chart · PNG
AVXL sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.1563% | |
| -8.3596% | |
| -7.8347% | |
| 44.9324% | |
| 53.9799% | |
| -14.4596% | |
| 14.3163% | |
| 19.5855% | |
| -39.9108% | |
| 72.313% | |
| 116.2667% | |
| 19.6962% | |
| 12.576% | |
| -53.545% | |
| 22.7118% | |
| 12.2575% | |
| -31.5646% | |
| 513.0524% | |
| 2,326.6918% | |
| -72.1698% | |
| 0% | |
| 0% |